Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...
Please provide your email address to receive an email when new articles are posted on . I would like to share a few thoughts on presbyopia-correcting IOLs. This has been an area of personal interest ...
Patients now have several exciting—although not yet perfect—multifocal intraocular lenses (IOLs) for presbyopia correction from which to choose. Currently in the United States, the recently approved ...
GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available ...
Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2%31-34; PanOptix® Trifocal IOL, implanted over 2.2 ...
Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Presbyopia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
Patients who have a new type of lens implanted in their eyes during surgery for cataracts or to correct their eyesight have excellent or good vision over distances both near and far, and often no ...
Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...
Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback